Obesity-related cardiorenal disease: the benefits of bariatric surgery (Q38126800)

29 August 2017

Obesity-related cardiorenal disease: the benefits of bariatric surgery (English)

1 reference

29 August 2017

0 references

0 references

5

Ara Darzi

1 reference

29 August 2017

Thanos Athanasiou

2

0 references

Leanne Harling

series ordinal

3

object named as

Leanne Harling

1 reference

29 August 2017

6

Hutan Ashrafian

1 reference

29 August 2017

Wiebke Fenske

1

1 reference

PubMed ID

23917797

29 August 2017

Christiane Drechsler

series ordinal

4

1 reference

PubMed ID

23917797

29 August 2017

language of work or name

English

0 references

publication date

6 August 2013

1 reference

29 August 2017

13

1 reference

Nature Reviews Nephrology

inferred from page(s)

published in

1 reference

29 August 2017

9

1 reference

29 August 2017

9

1 reference

29 August 2017

539-551

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2013.145

29 August 2017

0 references

cites work

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Obesity-related cardiorenal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Why is chronic kidney disease the "spoiler" for cardiovascular outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Renal function following long-term weight loss in individuals with abdominal obesity on a very-low-carbohydrate diet vs high-carbohydrate diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

The emperor's tailors: the failure of the medical weight loss paradigm and its causal role in the obesity of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Association of intentional changes in body weight with coronary heart disease event rates in overweight subjects who have an additional coronary risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Progressive regression of left ventricular hypertrophy two years after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

The effect of surgical weight reduction on left ventricular structure and function in severe obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Bariatric surgery and progression of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Bariatric surgery for morbid obesity: risks and benefits in chronic kidney disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Weight gain as a risk factor for clinical diabetes mellitus in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Identification and characterization of metabolically benign obesity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Characterizing the profile of obese patients who are metabolically healthy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Insulin-sensitive obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

The metabolically benign and malignant fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Human fatty liver disease: old questions and new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Adverse renal consequences of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Kidney pathological changes in metabolic syndrome: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Structural and functional changes in the kidneys of high-fat diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

New type of cardiomyopathy associated with diabetic glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Cardiac consequences of diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Evidence for cardiomyopathy in familial diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Ph

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Synthesis and dopamine D2-like receptor binding affinity of substituted 5-phenyl-pyrrole-3-carboxamides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

The metabolic basis of atherogenic dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Diabetes, hypertension, and cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Mechanisms of sympathetic activation in obesity-related hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Impact of obesity in intima media thickness of carotid arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Perturbed autonomic nervous system function in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Adipokines: inflammation and the pleiotropic role of white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Association of serum tumour necrosis factor-alpha with serum low-density lipoprotein-cholesterol and blood pressure in apparently healthy Japanese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Cardiovascular death and the metabolic syndrome: role of adiposity-signaling hormones and inflammatory markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Cytokines and vascular reactivity in resistance arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Vascular inflammation: a role in vascular disease in hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Identification of targets of leptin action in rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Role of selective leptin resistance in diet-induced obesity hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Sympathetic and cardiorenal actions of leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Cardiovascular consequences of obesity: role of leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Hyperleptinaemia: the missing link in the, metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Leptin and renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Leptin as a cardiac hypertrophic factor: a potential target for therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Hyperleptinaemia in chronic heart failure. Relationships with insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Leptin and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

HOMA, QUICKI and MFfm to measure insulin resistance in morbid obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Association of adrenal steroids with hypertension and the metabolic syndrome in blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Circulating and tissue angiotensin systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Aldosterone: effects on the kidney and cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Role of aldosterone in the remnant kidney model in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Subtle acquired renal injury as a mechanism of salt-sensitive hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Subtle renal injury is likely a common mechanism for salt-sensitive essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

A unifying pathway for essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Hyperuricemia in childhood primary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Association between serum uric acid levels and cardiometabolic risk factors among Japanese junior high school students.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

A causal role for uric acid in fructose-induced metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Hyperuricemia induces endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Uric acid and the development of metabolic syndrome in women and men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

The relationship between normal serum uric acid and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Effects of bariatric surgery on cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Cardiorenal syndrome: the emerging role of protein-bound uremic toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Perioperative safety in the longitudinal assessment of bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Bariatric surgery - can we afford to do it or deny doing it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Metabolic/bariatric surgery Worldwide 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Bariatric surgery and long-term cardiovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Are bariatric surgical outcomes worth their cost? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Metabolic surgery: an evolution through bariatric animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Regulation of renal function by the gastrointestinal tract: potential role of gut-derived peptides and hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Autobionics: a new paradigm in regenerative medicine and surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Metabolic surgery and obstructive sleep apnoea: the protective effects of bariatric procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Impact of body composition, fat distribution and sustained weight loss on cardiac function in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Reversible cardiomyopathies--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

In morbid obesity, metabolic abnormalities and adhesion molecules correlate with visceral fat, not with subcutaneous fat: effect of weight loss through surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Hyperghrelinemia is a common feature of Prader-Willi syndrome and pituitary stalk interruption: a pathophysiological hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Long-term prospective and controlled studies demonstrate adipose tissue hypercellularity and relative leptin deficiency in the postobese state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Long-term caloric restriction ameliorates the decline in diastolic function in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Is glycemic control improving in U.S. adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Can a protocol for glycaemic control improve type 2 diabetes outcomes after gastric bypass?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Combination of bypassing stomach and vagus dissection in high-fat diet-induced obese rats-a long-term investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Relationships between insulin release and taste.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Metabolic surgery and gut hormones - a review of bariatric entero-humoral modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Bariatric surgery versus conventional medical therapy for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Differential effect of weight loss on insulin resistance in surgically treated obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Severe recurrent hypoglycemia after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Pathogenesis of non-alcoholic steatohepatitis: human data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Non-alcoholic fatty liver disease: current concepts and management strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

The effects of weight loss on renal function in patients with severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Does treating obesity stabilize chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Obesity, proteinuria and progression of renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Obesity and renal transplantation: is bariatric surgery the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-aged Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Impact of Blood Pressure Control and Angiotensin-Converting Enzyme Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: A Post Hoc Analysis of the BENEDICT Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

High-Circulating Leptin Levels Are Associated with Greater Risk of Hypertension in Men Independently of Body Mass and Insulin Resistance: Results of an Eight-Year Follow-Up Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Waist circumference reduction and cardiovascular benefits during weight loss in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Magnetic resonance imaging of total body fat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Metabolically healthy but obese individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

β3-Adrenergic Receptors on White and Brown Adipocytes Mediate β3-Selective Agonist-induced Effects on Energy Expenditure, Insulin Secretion, and Food Intake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Low glomerular density with glomerulomegaly in obesity-related glomerulopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Left Ventricular Hypertrophy, Compliance and Ventricular Filling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Insulin stimulates production and secretion of endothelin from bovine endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Assessing obesity: are ethnic differences in body mass index and waist classification criteria justified?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Insulin resistance and hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Biomedicine. A sympathetic defense against obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Cardiac autonomic dysfunction in obese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Assessment of cardiac autonomic control by heart period variability in patients with early-onset familial obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Sympathetic activation in obese normotensive subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Hypoxia and the endocrine and signalling role of white adipose tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Blood pressure and inflammation in apparently healthy men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Role of corticotrophin-releasing factor in effects of leptin on sympathetic nerve activity and arterial pressure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Regulation of renal ouabain-resistant Na+-ATPase by leptin, nitric oxide, reactive oxygen species, and cyclic nucleotides: implications for obesity-associated hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

A neutralizing leptin receptor antibody mitigates hypertrophy and hemodynamic dysfunction in the postinfarcted rat heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Elevated serum uric acid predicts angiographic impaired reperfusion and 1-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Resurrection of uric acid as a causal risk factor in essential hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Uric acid levels, even in the normal range, are associated with increased cardiovascular risk: the Guangzhou Biobank Cohort Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Serum uric acid is associated with microalbuminuria in prehypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Prevalence of the metabolic syndrome in individuals with hyperuricemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Metabolic effects of dietary fructose

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

31 March 2020

12 December 2020

Heart remodelling and obesity: the complexities and variation of cardiac geometry

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Low responsiveness of cardiac adenylate cyclase activity to peptide hormones in spontaneously hypertensive rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

How big a problem is non-alcoholic fatty liver disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Impact of restrictive (sleeve gastrectomy) vs hybrid bariatric surgery (Roux-en-Y gastric bypass) on lipid profile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

The effect of weight loss after bariatric surgery on albuminuria.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Improvement and stabilization of chronic kidney disease after gastric bypass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.145

Insulin resistance and cardiovascular disease

31 March 2020

1 reference

12 December 2020

A Comparison of Natriuresis after Oral and Intravenous Sodium Loading in Sodium-Depleted Man: Evidence for a Gastrointestinal or Portal Monitor of Sodium Intake

1 reference

12 December 2020

The cardiorenal syndrome: a review

1 reference

12 December 2020

Effects of diet-therapy on urinary protein excretion albuminuria and renal haemodynamic function in obese diabetic patients with overt nephropathy

1 reference

12 December 2020

Increase in high molecular weight adiponectin by bariatric surgery-induced weight loss

1 reference

12 December 2020

Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells

1 reference

12 December 2020

Vipoma of the pancreas: observations on the diarhrhea and circulatory disturbances

1 reference

12 December 2020

Does leptin predict incident hypertension in older adults?

1 reference

12 December 2020

Renal effects of insulin in man.

1 reference

12 December 2020

Hyperleptinemia--non-haemodynamic risk factor for the left ventricular hypertrophy development in hypertensive overweight females

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2013.145

1 reference

29 August 2017

1 reference

PubMed ID

23917797